"Bone Diseases, Metabolic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Descriptor ID |
D001851
|
| MeSH Number(s) |
C05.116.198 C18.452.104
|
| Concept/Terms |
Bone Diseases, Metabolic- Bone Diseases, Metabolic
- Metabolic Bone Diseases
- Bone Disease, Metabolic
- Disease, Metabolic Bone
- Diseases, Metabolic Bone
- Metabolic Bone Disease
|
Below are MeSH descriptors whose meaning is more general than "Bone Diseases, Metabolic".
Below are MeSH descriptors whose meaning is more specific than "Bone Diseases, Metabolic".
This graph shows the total number of publications written about "Bone Diseases, Metabolic" by people in this website by year, and whether "Bone Diseases, Metabolic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Diseases, Metabolic" by people in Profiles.
-
Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment. Osteoporos Int. 2020 Jul; 31(7):1283-1290.
-
Bone loss in women with BRCA1 and BRCA2 mutations. Gynecol Oncol. 2018 03; 148(3):535-539.
-
Trends in bisphosphonate initiation within an integrated healthcare delivery system. Am J Manag Care. 2017 Dec 01; 23(12):e421-e422.
-
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg. 2012 Aug; 70(8):1844-53.
-
Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant. 2012 Jul; 27(7):2899-907.
-
Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines. J Bone Miner Res. 2010 Jul; 25(7):1506-11.
-
Early discontinuation of treatment for osteoporosis. Am J Med. 2003 Aug 15; 115(3):209-16.
-
The association of bone mineral density and depression in an older population. J Am Geriatr Soc. 2001 Jun; 49(6):732-6.